T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Marqeta
MQ
$1.75B
| $185M | 0.02% |
11,370,411
-1,917,211
| -14% | -$31.1M |
|
527
MP Materials
MP
$8.4B
| $183M | 0.02% |
3,273,205
+1,879,748
| +135% | +$114M |
|
528
National Fuel Gas
NFG
$7.53B
| $182M | 0.02% |
2,359,113
-509,593
| -18% | -$42.2M |
|
529
Liberty Media Corporation Series C Common Stock
FWONK
$23.6B
| $181M | 0.02% |
1,905,029
-314,211
| -14% | -$28.1M |
|
530
Cogent Biosciences
COGT
$5.45B
| $180M | 0.02% |
4,652,727
+1,439,912
| +45% | +$50.4M |
|
531
Emcor
EME
$34B
| $179M | 0.02% |
215,216
+114,877
| +114% | +$97.2M |
|
532
Norwegian Cruise Line
NCLH
$6.64B
| $179M | 0.02% |
8,457,110
+480,623
| +6% | +$8.97M |
|
533
ICICI Bank
IBN
$98.1B
| $178M | 0.02% |
6,116,835
+1,687,598
| +38% | +$45.6M |
|
534
Toast
TOST
$17.2B
| $177M | 0.02% |
6,348,787
+1,838,884
| +41% | +$48M |
|
535
Lincoln National
LNC
$7.95B
| $177M | 0.02% |
4,993,803
+565,854
| +13% | +$20.3M |
|
536
Plexus
PLXS
$6.97B
| $176M | 0.02% |
586,898
+508,075
| +645% | +$133M |
|
537
Itaú Unibanco
ITUB
$87.8B
| $175M | 0.02% |
21,440,675
+703,526
| +3% | +$5.83M |
|
538
KE Holdings
BEKE
$18.5B
| $175M | 0.02% |
12,026,502
+800,695
| +7% | +$13.2M |
|
539
Celldex Therapeutics
CLDX
$2.4B
| $174M | 0.02% |
4,685,223
+2,598,891
| +125% | +$83.9M |
|
540
10x Genomics
TXG
$11.3B
| $174M | 0.02% |
4,539,007
+4,375,792
| +2,681% | +$115M |
|
541
Vaxcyte
PCVX
$8.39B
| $174M | 0.02% |
2,988,999
+2,012,570
| +206% | +$109M |
|
542
Main Street Capital
MAIN
$5.15B
| $173M | 0.02% |
3,342,499
+633,696
| +23% | +$33.4M |
|
543
DuPont de Nemours
DD
$17.7B
| $173M | 0.02% |
1,275,087
+12,985
| +1% | +$1.84M |
|
544
Extreme Networks
EXTR
$2.77B
| $172M | 0.02% |
5,325,298
+5,170,947
| +3,350% | +$125M |
|
545
Vera Therapeutics
VERA
$2.29B
| $172M | 0.02% |
4,012,936
-561,094
| -12% | -$20.9M |
|
546
Enpro
NPO
$6.58B
| $171M | 0.02% |
454,568
+6,862
| +2% | +$2.13M |
|
|
SMA
547
SmartStop Self Storage REIT
SMA
$1.76B
| $171M | 0.02% |
5,270,721
-698,822
| -12% | -$22.2M |
|
548
Blackstone
BX
$87.2B
| $171M | 0.02% |
1,450,901
-151,307
| -9% | -$18.2M |
|
549
T. Rowe Price Growth Stock ETF
TGRW
$1.05B
| $171M | 0.02% |
3,573,401
+278,400
| +8% | +$12.9M |
|
550
Roivant Sciences
ROIV
$26.2B
| $170M | 0.02% |
4,816,741
-2,175,395
| -31% | -$64.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.